Moderna in talks to launch single-dose Covid vaccine in India

Moderna could launch a single-dose COVID-19 vaccine in India by 2022. The American vaccine maker is in talks with several Indian firms including Cipla. It is learned that Cipla has evinced interest to procure 50 million doses from Moderna for 2022. Cipla has also requested the central government for stability in regulatory requirements. It has been reported that these vaccines may not be available because of a waiting list. Moderna has already told India that it does not have any surplus vaccines in 2021 but media reports indicate that Pfizer on the other hand is ready to offer 50 million shots in 2021. Although they wants significant regulatory relaxations including indemnification. According to Pfizer, around 116 countries including the US have signed the indemnification document. To get the vaccines India's central government will have to buy them directly from the company. India has administered 200 million doses since launching the vaccination drive in mid-January.